Adenoviral natural born killer gene therapy for malignant glioma

Human Gene Therapy

Volumn 14, Issue 13, 2003, Pages 1235-1246

  Naumann, Ulrike ^a   Schmidt, Friederike ^a   Wick, Wolfgang ^a   Frank, Brigitte ^a   Weit, Simone ^a   Gillissen, Bernd ^b   Daniel, Peter ^b   Weller, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL 3; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME RELEASE; FLUOROMETRY; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; TRANSGENE;

ADENOVIRIDAE; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, NORTHERN; CASPASES; CELL LINE, TUMOR; FLUOROMETRY; GENE EXPRESSION; GENE THERAPY; GENES, BCL-2; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; PRECIPITIN TESTS; PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 0041381215     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403767740777     Document Type: Article

References (20)

1. DANIEL, P.T., PUN, K.W., RITSCHEL, S., STURM, I., HOLLER, J., DÖRKEN, B., and BROWN, R. (1999). Expression of the death gene Bik/Nbk promotes sensitivity of drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood 94, 1100-1107.
2. DEVERAUX, Q.L., LEO, E., STENNICKE, H.R., WELSH, K., SALVESEN, G.S., and REED, J.C. (1999). Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18, 5242-5251.
3. ELANGOVAN, B., and CHINNADURAI, G. (1997). Functional dissection of the pro-apoptotic protein Bik: Heterodimerization with anti-apoptosis proteins is not sufficient for induction of cell death. J. Biol. Chem. 272, 24494-24498.
4. GLASER, T., WAGENKNECHT, B., GROSCURTH, P., KRAMMER, P.H., and WELLER, M. (1999). Death ligand/receptor-independent caspase activation mediates drug-induced cell death in malignant glioma cells. Oncogene 18, 5044-5053.
5. GLASER, T., WAGENKNECHT, B., and WELLER, M. (2001). Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene 20, 4757-4767.
6. HAN, J., SABBATINI, P., and WHITE, E. (1996). Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 1, 5857-5864.
7. L, is a potent death agonist. J. Biol. Chem. 273, 7783-7786.
8. ISHII, N., MAIER, D., MERLO, A., TADA, M., SAWAMURA, Y., DISERENS, A.C., and VAN MEIR, E.G. (1999). Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 3, 469-479.
9. LUTZ, R.J. (2000). Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins. Biochem. Soc. Trans. 2, 51-56.
10. MATHAI, J.P., GERMAIN, M., MARCELLUS, R.C., and SHORE, G.C. (2002). Induction and endoplasmatic reticulum location of BIK/NBK in response to apoptotic signaling in E1A and p53. Oncogene 21, 2534-2544.
11. NAUMANN, U., KÜGLER, S., WOLBURG, H., WICK, W., RASCHER, G., SCHULZ, J.B., CONSEILLER, E., BÄHR, M., and WELLER, M. (2001). Chimeric tumor suppressor 1 (CTS1), a p53-derived chimeric tumor suppressor gene, kills p53 mutant- and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand. Cancer Res. 61, 5833-5842.
12. PUTHALAKATH, H., and STRASSER, A. (2002). Keeping killers on a tight leash: Transcriptional and post-translational control of the proapoptotic activity of BH3-only proteins. Cell Death Differ. 9, 505-512.
13. RADETZKI, S., KOHNE, C.H., VON HAEFEN, C., GILLISSEN, B., STURM, I., DÖRKEN, B., and DANIEL, P. (2002). The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene 21, 227-238.
14. SHIMIZU, S., and TSUJIMOTO, Y. (2000). Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc. Natl. Acad. Sci. U.S.A. 97, 577-590.
15. VERMA, S., ZHAO, L., and CHINNADURAI, G. (2001). Phosphorylation of the proapoptotic protein BIK: Mapping of phosphorylation sites and effects of apoptosis. J. Biol. Chem. 276, 4671-4676.
16. WAGENKNECHT, B., GLASER, T., NAUMANN, U., KÜGLER, S., ISENMANN, S., BÄHR, M., KORNELUK, R., LISTON, P., and WELLER, M. (1999). Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ. 6, 370-376.
17. WELLER, M., MALIPIERO, U.V., AGUZZI, A., REED, J.C., and FONTANA, A. (1995). Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95, 2633-2643.
18. WELLER, M., WINTER, S., SCHMIDT, C., ESSER, P., FONTANA, A., DICHGANS, J., and GROSCURTH, P. (1997). Topoisomerase I inhibitors for human malignant glioma: Differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone. Int. J. Cancer 73, 707-714.
19. WELLER, M., RIEGER, J., GRIMMEL, C., VAN MEIR, E.G., DE TRIBOLET, N., KRAJEWSKI, S., REED, J.C., VON DEIMLING, A., and DICHGANS, J. (1998). Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. Int. J. Cancer 79, 640-644.
20. ZOU, Y., PENG, H., ZHOU, B., WEN, Y., WANG, S.C., TSAI, E.M., and HUNG, M.C. (2002). Systemic tumor suppression by the proapoptotic gene bik. Cancer Res. 62, 8-12.